David M. Ota

Medicine · Health Sciences

40h-index7.9kcitations148works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Surgical Treatments(35), Colorectal and Anal Carcinomas(28), Gastric Cancer Management and Outcomes(20), Colorectal Cancer Treatments and Studies(15), Glycosylation and Glycoproteins Research(14)

Publications148 total

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
UNC Libraries·2020Open Access
Characteristics of breast cancers due to difference in mammographic breast density
European Journal of Cancer·2018
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
Journal of Clinical Oncology·2017· 404 citedOpen Access
Abstract PD07-01: Z1031B Neoadjuvant Aromatase Inhibitor Trial: A Phase 2 study of Triage to Chemotherapy Based on 2 to 4 week Ki67 level > 10%.
Cancer Research·2012· 14 cited
Microscopically Positive Margins for Primary Gastrointestinal Stromal Tumors: Analysis of Risk Factors and Tumor Recurrence
Journal of the American College of Surgeons·2012· 170 citedOpen Access
Comprehensive Genomic Studies
American Journal of Clinical Pathology·2012· 11 citedOpen Access
Whole-genome analysis informs breast cancer response to aromatase inhibition
Nature·2012· 1.0k citedOpen Access
Whole genome sequencing to characterize luminal-type breast cancer.
Journal of Clinical Oncology·2012· 2 cited
Abstract LB-423: Whole genome comparisons of pre- and post- aromatase inhibitor treatment in estrogen receptor positive breast cancer
Cancer Research·2012
Features Associated with Successful Recruitment of Diverse Patients onto Cancer Clinical Trials: Report from the American College of Surgeons Oncology Group
Annals of Surgical Oncology·2011· 40 citedOpen Access
American College of Surgeons Oncology Group and the Community Surgeon
Surgical Oncology Clinics of North America·2011· 1 citedOpen Access
Abstract LB-87: Analysis of luminal-type breast cancer by massively parallel sequencing
Cancer Research·2011· 1 cited
Chemoradiation (CRT) Safety Analysis of ACOSOG Z6041: A Phase II Trial of Neoadjuvant (NEO) CRT followed by Local Excision (LE) in uT2 Rectal Cancer (RC)
International Journal of Radiation Oncology*Biology*Physics·2010Open Access
Node biopsy vs. full lymph node dissection for breast cancer.
PubMed·2010
Changing multidisciplinary cancer treatment through ACOSOG trials.
PubMed·2010
Promoting patient safety through peer review.
PubMed·2010· 1 cited
Promoting patient safety.
PubMed·2009· 2 cited
The American College of Surgeons Oncology Group
Surgery·2009· 35 cited
A phase II trial for minimally invasive esophagectomy.
PubMed·2008
Development of a Queriable Database for Oncology Outcome Analysis
Medical radiology·2008· 3 cited
page 1 of 8Next →

Frequent Co-authors

Karen R. Cleary(13), Tatsuro Irimura(11), Jaffer A. Ajani(8), Tyvin A. Rich(6), Takao Yamori(5), Paul F. Mansfield(4), John M. Skibber(4), Boris W. Kuvshinoff(4), Bernard Levin(3), Patrick M. Lynch(3), Stuart D. Hoff(3), Yosuke Matsushita(3), J. Milburn Jessup(3), Barry W. Feig(3), Edward M. Copeland(3), Heidi Nelson(3), Matthew J. Ellis(2), Jingqin Luo(2), Vera J. Suman(2), Jeremy Hoog(2)